Evidence map›Paper›PMID 42206201›Full record

ArticleAJOG global reports2026

Guideline adherence to aspirin prophylaxis use for preeclampsia among healthcare providers in Northwest Ethiopia: an explanatory sequential mixed-methods study.

Samuel Berihun Dagnew, Desalegn Addis Mussie, Tilaye Arega Moges, Samuel Agegnew Wondm, Woretaw Sisay Zewdu, Abel Temeche Kassaw, Tigabu Eskeziya Zerihun, Getachew Yitayew Tarekegn, Fasil Bayafers Tamene, Abaynesh Fentahun Bekalu

Abstract read
In one paragraph

Article in AJOG global reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Samuel Berihun DagnewDepartment of Clinical Pharmacy (Dagnew, Mussie, Moges, Wondm, Kassaw, Zerihun and Tarekegn), Pharmacy Education and Clinical Service Directorate, Debre Tabor University, Debre Tabor, Ethiopia.
Desalegn Addis MussieDepartment of Clinical Pharmacy (Dagnew, Mussie, Moges, Wondm, Kassaw, Zerihun and Tarekegn), Pharmacy Education and Clinical Service Directorate, Debre Tabor University, Debre Tabor, Ethiopia.
Tilaye Arega MogesDepartment of Clinical Pharmacy (Dagnew, Mussie, Moges, Wondm, Kassaw, Zerihun and Tarekegn), Pharmacy Education and Clinical Service Directorate, Debre Tabor University, Debre Tabor, Ethiopia.
Samuel Agegnew WondmDepartment of Clinical Pharmacy (Dagnew, Mussie, Moges, Wondm, Kassaw, Zerihun and Tarekegn), Pharmacy Education and Clinical Service Directorate, Debre Tabor University, Debre Tabor, Ethiopia.
Woretaw Sisay ZewduDepartment of Pharmacology (Zewdu), Pharmacy Education and Clinical Service Directorate, Debre Tabor University, Debre Tabor, Ethiopia.
Abel Temeche KassawDepartment of Clinical Pharmacy (Dagnew, Mussie, Moges, Wondm, Kassaw, Zerihun and Tarekegn), Pharmacy Education and Clinical Service Directorate, Debre Tabor University, Debre Tabor, Ethiopia.
Tigabu Eskeziya ZerihunDepartment of Clinical Pharmacy (Dagnew, Mussie, Moges, Wondm, Kassaw, Zerihun and Tarekegn), Pharmacy Education and Clinical Service Directorate, Debre Tabor University, Debre Tabor, Ethiopia.
Getachew Yitayew TarekegnDepartment of Clinical Pharmacy (Dagnew, Mussie, Moges, Wondm, Kassaw, Zerihun and Tarekegn), Pharmacy Education and Clinical Service Directorate, Debre Tabor University, Debre Tabor, Ethiopia.
Fasil Bayafers TameneDepartment of Pharmacy (Tamene), College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia.
Abaynesh Fentahun BekaluDepartment of Clinical pharmacy (Bekalu), School of Pharmacy, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPreeclampsia is a significant cause of illness and mortality among mothers and newborns, especially in countries with limited resources. Preeclampsia is less common when low-dose aspirin (LDA) is used early in high-risk pregnancies.

objectiveThe purpose of this study was to evaluate aspirin prophylaxis guideline adherence among Northwest Ethiopian healthcare providers (HCPs). STUDY

designA sequential mixed-methods explanatory research was carried out in three tertiary hospitals between March and May of 2025. Using a standardized questionnaire based on WHO, ACOG, and NICE standards, quantitative data was gathered from 304 HCPs who were chosen at random. Logistic regression was used to examine adherence-related characteristics. Qualitative perspectives were investigated through in-depth interviews with providers who were specifically chosen.

resultsAmong 304 participants (mean age 29.8 ± 4.7 years; 56.6% male), nurses (38.2%) and midwives (32.6%) predominated. Only 41.4% had adequate knowledge, 54.3% held a positive attitude, and 34.9% exhibited good adherence to guidelines. Poor knowledge (AOR = 3.42), negative/uncertain attitude (AOR = 2.67), and <5 years of experience (AOR = 1.89) were independently associated with poor adherence. Qualitative findings identified four themes: knowledge gaps, safety concerns, system-level barriers (absence of national guideline, drug stock-outs, high workload), and limited experience/mentorship.

conclusionAdherence to aspirin prophylaxis guidelines is not optimal. To improve maternal outcomes, specific training, mentorship, supportive supervision, and the creation of national guidelines must address knowledge gaps, attitudes, clinical experience, and systemic barriers.

Indexed as

aspirin prophylaxis, guideline adherence, nonadherencefailure, Northwest Ethiopia, preeclampsia, quantitative and qualitative analysis, reasons for nonadherence

Identifiers

PMID42206201
PMCPMC13208822

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.